Business Practice

PhRMA weeds out 22 members after revising membership rules.

Is growing awareness of unwanted drug effects good or bad for patients?

Charlotte Barker speaks with Lukas Utiger from Patheon.

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

President Trump has the opportunity to get healthcare moving by boosting biogeneric use.

Bribery accusations, a new whistleblowing policy, and recalls... What’s new for pharma in business?

Celebrating the great and good of drug development: welcome to The Medicine Maker 2017 Power List

Should the UK National Health Service manufacture some generic drugs?

Marathon sells Emflaza, but questions remain about FDA approval processes.

Pharma has a number of underlying structural issues. It's time for a change of direction.